Issued Patents 2020
Showing 1–7 of 7 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10849986 | Antibody-drug conjugates and uses thereof | David M. Goldenberg | 2020-12-01 |
| 10751420 | Antibody-SN-38 immunoconjugates with a CL2A linker | Jonathan B. Gale, Nicholas J. Holman, David M. Goldenberg | 2020-08-25 |
| 10744129 | Therapy of small-cell lung cancer (SCLC) with a topoisomerase-I inhibiting antibody-drug conjugate (ADC) targeting Trop-2 | David M. Goldenberg | 2020-08-18 |
| 10709701 | Efficacy of anti-HLA-DR antibody drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR positive cancers | Thomas M. Cardillo, David M. Goldenberg | 2020-07-14 |
| 10682347 | Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity | David M. Goldenberg | 2020-06-16 |
| 10653793 | Antibody-drug conjugates and uses thereof | David M. Goldenberg | 2020-05-19 |
| 10561738 | Immunoconjugates with an intracellularly-cleavable linkage | Sung-Ju Moon, David M. Goldenberg | 2020-02-18 |